Trend Results : Alzheimer's Disease


Blog Post Results (1-20 of 5815)

FILTER RESULTS

"Rambling and long-winded anecdotes could be an early sign of Alzheimer’s disease..."

"... according to research that suggests subtle changes in speech style occur years before the more serious mental decline takes hold."“Ronald Reagan started to have a decline in the number of unique words with repetitions of statements...Show More Summary

Long-winded speech could be early sign of Alzheimer's, says study

Research finds distinctive language deficits in people with mild cognitive impairment, a precursor to dementia Rambling and long-winded anecdotes could be an early sign of Alzheimer’s disease, according to research that suggests subtle changes in speech style occur years before the more serious mental decline takes hold. Show More Summary

Postmenopausal hormone therapy may help prevent dementia

The University of Eastern Finland has found an association between postmenopausal estrogen-based hormone therapy and a decreased risk of Alzheimer’s disease. Alzheimer’s is one of the most prevalent forms of dementia, especially among...Show More Summary

Solving the puzzle of Alzheimer's disease

A new study examines if a compound called AC253 can inhibit a 'rogue' protein called amyloid. The protein is found in large numbers in the brains of Alzheimer's patients and is suspected to be a key player in the development of the disease.

9 steps for better brain health

Dementia and Alzheimer’s disease cases are on the rise as the world’s population gets older. These brain disorders are associated with significant memory loss and can impair one’s ability to care for themselves. As time goes by, a person’s memory … The post 9 steps for better brain health appeared first on Bel Marra Health - Breaking Health News and Health Information.

Disappointing Merck drug news underscores critical next steps in Alzheimer's fight

(Amplify Public Affairs) UsAgainstAlzheimer's, which works collaboratively with industry partners to see near- and long-term progress against this destructive disease, applauds the vast investment of Merck, the diligence of the manyShow More Summary

The new offensive on Alzheimer’s disease

4 days agoNews : The Raw Story

Close The announcement came the day before Thanksgiving, but there was nothing in it to be thankful for: An experimental Alzheimer’s drug many thought would slow the disease’s steady cognitive decline had failed to make a significant difference in a massive trial of people with early signs of the...

Postmenopausal hormone therapy exceeding ten years may protect from dementia

Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study. The study explored the association between postmenopausal hormone replacement therapy,...Show More Summary

Solving the puzzle of Alzheimer's disease

(University of Alberta Faculty of Medicine & Dentistry) A new study published by UAlberta researchers in the journal Alzheimer's and Dementia: Translational Research and Clinical Intervention examines if a compound called AC253 can inhibit a 'rogue' protein called amyloid. Show More Summary

Alzheimer’s disease drug fails in trial

Merck is halting a trial of verubecestat, an Alzheimer's disease medication. The pharmaceuticals company concluded the drug has “virtually no chance of finding a positive clinical effect.” The trial, called the EPOCH study, tested the efficacy and safety of the drug when taken orally in people with mild-to-moderate Alzheimer's disease. While this study was stopped, Dr. Roger […]

A method based on artificial intelligence allows to diagnose Alzheimer's or Parkinson's

(University of Granada) Alzheimer's disease, which currently affects more than 40 million people, is the most common neurodegenerative disease in elder people. Early diagnosis is crucial both to treat the disease and to help the development of new medicines, as it hasn't been possible to find a cure so far.

Key Alzheimer’s drug shows ‘virtually no chance of working’

The failure of another drug that targets beta amyloid plaques in the brains of people with Alzheimer’s has revived doubts over whether plaque causes the disease

Postmenopausal hormone therapy exceeding ten years may protect from dementia

(University of Eastern Finland) Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland. Show More Summary

The New Offensive on Alzheimer’s Disease: Stop it Before it Starts

Not a single medicine has been shown to slow the progression of the disease, so researchers are taking an aggressive new approach.

Exercise Boosts Grey Matter, Reduces Alzheimer’s Risk

The rate of Alzheimer’s disease and other types of dementia are estimated to double every 20 years. On average a person is diagnosed with dementia every 3.2 seconds. In the face of such sobering statistics a new study offers some hope; it suggests that physically active people are less likely to develop Alzheimer’s disease. Show More Summary

Study: Hormone Therapy May Not Protect Against Alzheimer's Disease

The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later. Some previous studies have shown that hormone therapy may increase the risk of the disease, while others have shown that it may reduce the risk. Show More Summary

Validation of suspected somatic single nucleotide variations

(IOS Press) It has been proposed that somatic gene variations (SNV) present in few brain cells could facilitate the development of neurodegenerative disorders like Alzheimer's disease.

Is it depression or dementia? Brain SPECT imaging helps distinguish them

(IOS Press) Does a patient have depression or a cognitive disorder (CD) such as Alzheimer's disease or both? Since both disorders have overlapping symptoms, how can a clinician tell them apart to make an appropriate diagnosis? In a new...Show More Summary

Medical News Today: Calcium imbalance within brain cells may trigger Alzheimer's disease

New research examines the metabolism of brain cells and uncovers the calcium exchange mechanism that could lead to Alzheimer's disease.

Merck to halt study of mild to moderate Alzheimer's drug

(Reuters) - Merck & Co Inc said it would halt a late-stage trial of its drug in patients with mild to moderate Alzheimer's disease after an external panel pointed to a lack of effectiveness.

Copyright © 2015 Regator, LLC